TY  - GEN
AU  - Dhingra,K
AU  - Fritsche,H
AU  - Murray,J L
AU  - LoBuglio,A F
AU  - Khazaeli,M B
AU  - Kelley,S
AU  - Tepper,M A
AU  - Grasela,D
AU  - Buzdar,A
AU  - Valero,V
TI  - Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin
SN  - 0008-5472
PY  - 1995///0817
KW  - Adult
KW  - Aged
KW  - Antibiotics, Antineoplastic
KW  - adverse effects
KW  - Antibodies, Anti-Idiotypic
KW  - biosynthesis
KW  - Antibodies, Monoclonal
KW  - Antibody Formation
KW  - drug effects
KW  - Complement Activation
KW  - Complement C3
KW  - metabolism
KW  - Complement C4
KW  - Dose-Response Relationship, Drug
KW  - Drug Interactions
KW  - Female
KW  - Guanidines
KW  - Humans
KW  - Isoantigens
KW  - immunology
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -